Skip to main content
CNS Neuroscience & Therapeutics logoLink to CNS Neuroscience & Therapeutics
. 2018 Jun 27;25(1):101–111. doi: 10.1111/cns.13002

Tobacco and cannabis use in college students are predicted by sex‐dimorphic interactions between MAOA genotype and child abuse

Paula J Fite 1,2,, Shaquanna Brown 1,2, Waheeda Hossain 1,3, Ann Manzardo 1,3, Merlin G Butler 1,3, Marco Bortolato 1,4,5,
PMCID: PMC6436599  PMID: 29952131

Summary

Background

Postsecondary students in Western countries exhibit a high prevalence of cannabis and tobacco use disorders. The etiology of these problems is contributed by several psychosocial factors, including childhood adversity and trauma; however, the mechanisms whereby these environmental determinants predispose to the use of these substances remain elusive, due to our poor knowledge of genetic and biological moderators. Converging evidence points to the monoamine oxidase A (MAOA) gene as a moderator of the effects of lifetime stress on the initiation of substance use.

Aims

Building on these premises, in this study, we analyzed whether MAOA upstream variable number tandem repeat (uVNTR) alleles interact with child maltreatment history to predict for lifetime cannabis and tobacco consumption.

Materials and methods

Five hundred college students (age: 18–25 years) from a large Midwestern University were surveyed for their child maltreatment history (encompassing emotional, physical, and sexual abuse, as well as emotional and physical neglect) and lifetime consumption of cannabis and tobacco. Saliva samples were obtained to determine the MAOA uVNTR genotype of each participant.

Results

In female students, lifetime tobacco and cannabis use was predicted by the interaction of physical and emotional abuse with high‐activity MAOA allelic variants; conversely, in males, the interaction of low‐activity MAOA alleles and physical abuse was associated with lifetime use of tobacco, but not cannabis.

Discussion

These findings collectively suggest that the vulnerability to smoke tobacco and cannabis is predicted by sex‐dimorphic interactions of MAOA gene with childhood abuse.

Conclusion

These biosocial underpinnings of tobacco and cannabis use may prove important in the development of novel personalized preventive strategies for substance use disorders in adolescents.

Keywords: cannabis, child maltreatment, college students, MAOA, tobacco

1. INTRODUCTION

Epidemiological surveys in the USA and other Western countries have documented that students enrolled in postsecondary institutions display a high prevalence of problematic use of alcohol, tobacco, and cannabis.1, 2, 3, 4, 5, 6, 7, 8 The abuse of these substances results in enduring and severe consequences, including neurocognitive problems, poor academic performance, financial and legal repercussions, health concerns, as well as unintentional injuries and mortality.9, 10, 11, 12, 13, 14 Better interventional strategies are needed for the prevention of substance use in this population, but these efforts are severely hampered by our inadequate understanding of the etiology of substance use vulnerability.

Early initiation of drug use is arguably one of the most critical risk factors for abuse, dependence, and other substance‐related problems in adulthood15, 16 and has been shown to be influenced by shared genetic and environmental vulnerability factors.17, 18, 19, 20, 21, 22 Accordingly, the vulnerability for early substance use in adolescents is increased by child adversity and trauma,22, 23, 24, 25, 26, 27, 28, 29, 30 as well as shared and drug‐specific genetic factors.31, 32, 33

A growing body of evidence indicates that the risk of substance use (and particularly its early onset) is influenced by the gene encoding monoamine oxidase A (MAOA).34, 35, 36, 37, 38, 39, 40, 41, 42, 43, 44, 45, 46, 47, 48 This enzyme catalyzes the oxidative deamination of brain monoamine transmitters, including serotonin, norepinephrine, and dopamine,49 which play a key role in the mechanisms of stress response as well as the pathogenesis of substance abuse and dependence. The MAOA gene is located on the short arm of the X chromosome (Xp11.4‐p11.23).50, 51 The best‐characterized genetic variants of MAOA are related to an upstream variable number tandem repeat (uVNTR), featuring different numbers (2, 3, 3.5, 4, 5 and 6) of 30‐bp repeats located in the gene promoter.52, 53 Alleles harboring 2 and 3 repeats are associated with lower transcriptional efficiency than the other variants.52, 54, 55, 56

Numerous studies have shown that MAOA uVNTR alleles exert a sex‐dimorphic influence on the pathogenesis of alcohol‐related problems, often through gene × environment (G × E) interactions with early‐life psychosocial stress.35, 36, 37, 38, 39, 40, 41, 42 In males, low‐activity uVNTR variants (hereafter denominated MAOA‐L) predispose to earlier onset of alcoholism,34 alcohol dependence,34, 35 and antisocial alcoholism.36 In females, high‐activity alleles (MAOA‐H) predispose to alcohol consumption by interacting with poor‐quality family relations and a positive history of sexual abuse; conversely, maltreated MAOA‐L male carriers are at higher risk for alcohol use.42

The involvement of MAOA uVNTR alleles in G × E interactions is in agreement with rich evidence on other psychopathological states. In males, the interplay of MAOA‐L alleles with child maltreatment has been extensively shown to predispose to aggression, delinquency, and antisocial behavior57, 58, 59, 60, 61, 62, 63, 64; conversely, the interaction of MAOA‐H and early adversity has been shown to heighten the proclivity for antisocial and violent responses in females,65, 66, 67 likely due to an enhancement in emotional reactivity during adolescence.68 The interaction of MAOAL alleles and childhood adversity in females may influence depression vulnerability.69, 70 These sex‐dimorphic effects may reflect different influences of the MAOA‐uVNTR variants on monoamine metabolism between males and females.56, 71

In contrast with the rich evidence on alcohol‐related problems and other psychiatric disorders, little is currently known about the specific role of the G × E interaction of MAOA uVNTR alleles and early‐life maltreatment in use of tobacco and cannabis. Here, we surveyed 500 college students in a large Midwestern University to investigate whether tobacco and cannabis lifetime consumption may be predicted by the interaction of MAOA genotype, sex, and child maltreatment. Our rationale for focusing on lifetime cannabis and tobacco use was based on prior findings showing that: (i) uVNTR alleles may be particularly relevant in influencing the onset of substance use in early life34, 35; and (ii) cannabis lifetime use is largely influenced by genetic factors,33 and these factors largely overlap with those for cannabis abuse or dependence72, 73, 74; (iii) early substance use and misuse have been broadly linked to impulsivity and poor inhibitory control,75, 76, 77 behavioral domains widely influenced by MAOA genotype.38, 78, 79

2. METHODS

2.1. Participants

Five hundred students were recruited from introductory undergraduate Psychology courses at a large Midwestern University through a research recruitment system (SONA). However, due to missing data, analyses only included 470 participants (239 female). Demographic information (including age, sex and race/ethnicity) and descriptive statistics of this final sample are reported in Table 1. The majority of students (61.1%) were in their first year of college, identified as Caucasian (71.1%), and had parents with greater than a high school education (80.9% of fathers and 79.7% of mothers). MAOA genotype information broken down by sex and race/ethnicity is reported in Table 2. The MAOA‐H genotype was more common than MAOA‐L for males. The majority of females exhibited a heterozygous genotype (MAOA‐LH = 121); 44 and 74 were homozygous MAOA‐L and MAOA‐H carriers, respectively. According to power tables, our samples of >200 males and females had adequate power (α = 0.80) to detect moderate to larger MAOA × maltreatment effects for each sex.80

Table 1.

Participant demographics and descriptive statistics

Overall sample (n = 470) Males (n = 231) Females (n = 239)
M (SD) Age 18.95 (1.19) 19.14 (1.25) 18.76 (1.10)
Year in school
% 1st year student 61.1 55.8 66.1
%2nd year student 27.4 29.4 25.5
% 3rd year student 8.9 11.7 6.3
% 4th year student 1.9 2.6 1.3
% 5th year or more student 0.7 0.5 0.8
Race/Ethnicity
% Caucasian 71.1 72.7 69.5
% African American 3.6 3.0 4.2
% Hispanic/Latino 6.2 4.8 7.5
% Native American 1.3 .9 1.7
% Asian 10.6 10.4 10.9
% Mixed or other 7.2 8.2 6.2
Medical History
% Psychological disorder 13.2 10.4 15.9
% Current illness/injury 3.4 3.5 3.3
% Currently medications 43.4 25.1 61.1
Parental education at birth
% Fathers greater than high school 80.9 81.0 78.4
% Mothers greater than high school 79.7 83.8 78.2

Table 2.

MAOA variants

MAOA
Low activity High activity
Males 94 137
Caucasian 58 110
African American 3 4
Hispanic/Latino 6 5
Native American 1 1
Asian 16 8
Mixed or other 10 9
MAOA
Low activity Heterozygous High activity
Females 44 121 74
Caucasian 25 84 57
African American 3 4 3
Hispanic/Latino 3 12 3
Native American 0 1 3
Asian 12 10 4
Mixed or other 1 10 4

2.2. Procedures

This study was approved by the researchers’ institutional review board. Participants were asked to refrain from eating 1 hour before, as well as smoking, taking drugs (including prescription), caffeine, and alcohol at least 3 hours before their study appointment time. Written informed consent was obtained from all participants prior to study participation. At the beginning of the appointment, participants rinsed their mouths with water, and, approximately 10 minutes later, provided 2 mL of saliva via passive drool for genetic analysis. Participants then completed an online survey in approximately 1 hour, using Qualtrics software. To preserve the anonymity of all participants, they were given a unique ID number and no identifying information was collected. Due to the inclusion of items pertaining to a history of trauma, all participants received a list of local mental health care providers upon study completion. All subjects were compensated with a $5 debit card and 3 SONA course credits for study participation.

2.3. Measures

The survey encompassed the following measures:

2.3.1. Demographics

Participants answered several questions regarding demographic information, including their age, sex, and race/ethnicity.

2.3.2. Child maltreatment

Child maltreatment was assessed via the Childhood Trauma Questionnaire (CTQ;81), a self‐reported instrument that retrospectively measures exposure to abuse and neglect during childhood and adolescence. The measure includes 5 subscales (physical abuse, emotional abuse, sexual abuse, physical neglect, and emotional neglect) consisting of 5 items each, along with an overall child maltreatment score. Items are rated on a 5‐point Likert scale ranging from “Never True” to “Often True.” Mean scores were obtained and used for analyses, with higher scores indicating higher amounts of trauma exposure. Reliability and validity of the CTQ has been demonstrated in prior research.81 The physical neglect subscale yielded the lowest reliability coefficient (α = 0.56) in the current sample; conversely, internal consistencies for the remaining 4 subscales had αs > 0.81.

2.3.3. Lifetime substance use

Participants completed 2 dichotomous (0 = “no”, 1 = “yes”) items from the Center for Substance Abuse Prevention (CSAP) Student Survey,82 which assessed lifetime tobacco (ie, “Have you ever smoked a cigarette, even just a few puffs, or used chewing tobacco, snuff, or dip?”) and cannabis use (ie, “Have you ever tried marijuana?”).

2.4. MAOA uVNTR variants genotyping

DNA was extracted from salivary samples, using Saliva DNA Collection, Preservation, and isolation Kit (Norgen Biotek Corp, ON, Canada). MAOA‐uVNTR allelic variants were genotyped by PCR‐based amplification, with the following primers: forward, 5′‐ACAGCCTGACCGTGGAGAAG‐3′ labeled with the FAM fluorophore; and reverse, 5′‐GAACGGACGCTCCATTCGGA‐3′ PCR reactions contained 100 ng of template DNA, 1X PCR Master Mix (Thermo Scientific, Waltham, MA) 500 nmol/L of each primerin a total volume of 20 μL. After 2 minutes at 95°C, 35 cycles were carried out at 94°C for 30 seconds, at 60°C for 30 seconds, and at 72°C for 40 seconds, with a final extension at 72°C for 5 minutes. PCR products were assayed by sending 15 μL of PCR product to GENEWIZ LLC (Frederick, MD) for fragment analysis. Results were analyzed using Peak Scanner program (Applied Biosystems, Thermo Fisher, Waltham, MA). All laboratory procedures were carried out by operators blinded to experimental conditions and demographic data.

Male carriers of 2 and 3 repeat variants were designated as MAOA‐L; conversely, male carriers with 3.5 and 4 repeat alleles were considered MAOA‐H (see Table 2).

Females were designated as either MAOA‐L or MAOA‐H homozygous (depending on the same variants mentioned above), or heterozygous MAOA‐LH, if they carried a copy of each variant. To allow for comparability between males and females, however, we combined MAOA‐L homozygous and MAOA‐LH female participants, in agreement with previous functional studies on sex‐dimorphic effects of MAOA uVNTR variants.83, 84, 85, 86, 87 To confirm the validity of this approach with respect to our study, analyses were conducted with female participants in which G × E interactions between the MAOA genotype variants (MAOA‐L, MAOA‐H, and MAOA‐LH) and maltreatment types were evaluated. Results indicated that MAOA‐LH genotype operated in an equivalent fashion as the MAOA‐L genotype in its interaction with maltreatment types to predict tobacco and cannabis use.

Our analyses did not include carriers of 5‐repeat uVNTR alleles, as the actual functional significance of this variant remains controversial52, 54; in fact, the exclusion of 5‐repeat variant is in agreement with numerous previous studies on MAOA uVNTR.60

2.5. Data analysis

Analyses were conducted on 470 participants, as MAOA genotyping could not be undertaken for 11 participants, and an additional 11 participants were missing CTQ and/or substance use data; finally, 8 participants carrying 5‐repeat uVNTR alleles were excluded from the analyses. Chi‐square and mean difference tests indicated that there were no differences regarding sex or age for those whose data was included in analyses versus those who were excluded (ps > 0.48). Additionally, no differences in mean levels the child maltreatment variables were found (ps > 0.16). Logistic regression models were estimated using SPSS statistical software (IBM Corporation, Harmonk, NY) to evaluate proposed associations. The dichotomous lifetime substance use items were the dependent variables with sex, MAOA variants, the maltreatment types, and their interactive effects included as independent variables. Specifically, 3‐way interactions were evaluated one at a time (eg, sex × MAOA variants × physical abuse) to determine if child maltreatment‐MAOA interactive effects depended on sex. Note that all independent variables were mean centered prior to analyses to aid in interpretation of interaction effects. Statistically significant interactions were probed using simple slope analyses. Specifically, models were conditioned based on sex (male vs female) and for MAOA variants to determine the nature of the interactions, consistent with standard procedures.80

When a large number of analyses are conducted, Bonferroni's correction and other statistical methods aimed at reducing Type 1 error rates have been found to overcorrect and greatly reduce power to detect effects; in these cases, it has been therefore recommended to focus on effect sizes when interpreting results.88 Accordingly, significance was set at  0.05 and odds ratios were reported as an indicator of the magnitude of effects for statistically significant associations. Odds ratios (OR) are reported for significant effects to provide a measure of the magnitude of the effect. OR greater than 1 suggest an increase in odds of the outcome (ie, substance use) per 1 unit increase in the independent variable (ie, maltreatment type), and OR less than 1 indicate a decrease in odds of the outcome per each unit increase in the independent variable.89

3. RESULTS

3.1. Descriptive analyses

Approximately 41.9% reported tobacco use, and 55.8% indicated cannabis use. According to clinical cutoff scores recommended by Bernstein and Fink,81 approximately 46.5% of the sample had experienced at least low levels of at least one maltreatment type. These data are consistent with previous reports on undergraduate, emerging adult samples.90 Correlations between maltreatment types ranged from 0.23 to 0.59, suggesting that these maltreatment types share up to 35% of their variance with one another.

3.2. Lifetime tobacco use

A marginally significant 3‐way interaction involving any type of maltreatment × MAOA variants × sex was found (= 1.89, = 0.059; See Table 3). For MAOA‐L males, maltreatment exposure was associated with lifetime tobacco use (= 1.143, = 0.049), such that for every unit increase in trauma exposure the log of the odds of ever using tobacco increased by 3.14. However, for MAOA‐H males, trauma exposure was unrelated to tobacco use (= 0.088, = 0.84). In contrast, for females, trauma exposure was unrelated to tobacco use at MAOA‐L variants (= 0.382, = 0.25), but positively associated with MAOA‐H alleles (= 1.214, = 0.041). For MAOA‐H females, for every unit increase in trauma exposure, the log of the odds of ever using tobacco increased by 3.37.

Table 3.

Tobacco use 3‐way interaction estimates

Lifetime tobacco use
B P
Sexual abuse 1.70 0.15
Emotional neglect 0.13 0.82
Physical abuse 5.09 0.00
Emotional abuse 0.68 0.28
Physical neglect 0.44 0.65
Any maltreatment 1.89 0.059

When examining specific maltreatment types, only one significant 3‐way interaction emerged: physical abuse × MAOA variants × sex. Physical abuse was unrelated to lifetime tobacco use for MAOA‐H males (= −0.30, = 0.34). However, for MAOA‐L males, there was a trend for physical abuse to increase the likelihood of tobacco use (= 1.54, = 0.055), such that for every unit increase in physical abuse the log of the odds of using tobacco increased by 4.70 times. In contrast, physical abuse was unrelated to tobacco use for MAOA‐L females (= −0.43, = 0.31), but positively associated for MAOA‐H females (= 2.81, = 0.03). For MAOA‐H females, for every unit increase in physical abuse the log of the odds of ever using tobacco use increased by 16.67. Follow‐up 2‐way interactions were also evaluated; however, no significant 2‐way interactions emerged (ps > 0.17).

3.3. Lifetime cannabis use

When examining lifetime cannabis use, a significant 3‐way interaction involving any type of maltreatment × MAOA variants × sex was found (= 3.04, = 0.00; See Table 4). The probing of simple slopes indicated that an interactive effect between maltreatment and MAOA variants was unique to females; that is, trauma exposure was unrelated to lifetime cannabis use for both MAOA‐L (= 0.65, = 0.23) and MAOA‐H (= −0.67, = 0.15) males. Trauma exposure was also unrelated to cannabis use for MAOA‐L females (= −0.31, = 0.34); however, in MAOA‐H females, trauma exposure was associated with lifetime cannabis use (= 1.42, = 0.041), such that for every unit increase in trauma exposure, the log of the odds of ever using cannabis increased by 4.13 for females.

Table 4.

Marijuana use 3‐way interaction estimates

Lifetime marijuana use
B P
Sexual abuse −0.21 0.81
Emotional neglect 1.37 0.02
Physical abuse 4.40 0.00
Emotional abuse 1.39 0.03
Physical neglect 2.07 0.051
Any maltreatment 3.04 0.00

When examining specific maltreatment types results indicated 3‐way interactions for all maltreatment types but sexual abuse (See Table 4). However, the probing of simple slopes for both emotional neglect and physical neglect indicated that these maltreatment types were not associated with lifetime cannabis use for males or females at either MAOA‐H and MAOA‐L (Males MAOA‐H Bs = −0.27 & −0.41, ps > 0.29; males MAOA‐L Bs = 0.45 & 0.15, ps > 0.16; females MAOA‐H; Bs = 0.35 & 0.96, ps > 0.27; females MAOA‐L Bs = −0.31 & −0.56, ps > 0.23). This pattern of results indicates that, although results vary for males and females, no meaningful associations between child maltreatment type and risk for cannabis use are evident for males or females at high‐ or low‐activity MAOA alleles.

In contrast, the probing of simple slopes of the physical abuse and emotional abuse indicated that the interactive effects between maltreatment and MAOA variants depended on sex. For males, emotional abuse was positively associated with lifetime cannabis use at MAOA‐L (= 0.86, = 0.045) but unrelated at MAOA‐H (B = −0.02, = 0.95). Physical abuse was negatively associated with lifetime marijuana use for MAOA‐H males (= −0.76, = 0.03) and unrelated for MAOA‐L males (= 0.23, = 0.60). For MAOA‐L females, physical and emotional abuse were also unrelated to lifetime cannabis use (= −0.75 & −0.02, ps > 0.06). However, in MAOA‐H females, physical abuse increased the likelihood of cannabis use (= 2.66, = 0.04), such that, with every unit increase in physical abuse, the log of the odds of using cannabis increased by 14.25. Additionally, in MAOA‐H females, emotional abuse increased the likelihood of cannabis use (= 0.83, = 0.021), such that for every unit increase in emotional abuse, the log of the odds of using cannabis increased by 2.30 for females. Finally, 2‐way interactions revealed no significant 2‐way interactions (ps > 0.49).

4. DISCUSSION

The results of this study show that, in a sample of 470 students enrolled in a large Midwestern University, lifetime tobacco and cannabis use were predicted by the interaction between uVNTR allelic variants of MAOA gene and specific components of child maltreatment in a sex‐dimorphic fashion. Specifically, a positive history of physical abuse increased risk of lifetime tobacco consumption in MAOA‐L male and MAOA‐H female carriers; furthermore, MAOA‐H variants exacerbate the link between physical and emotional abuse and risk of cannabis use in females.

These findings extend and complement previous evidence on the link between early‐life adversities and substance use,91, 92, 93 as well as the role of MAOA as a vulnerability gene for substance use 34, 35, 36, 37, 38, 39, 40, 41, 42, 43, 44, 45, 46, 47, 48 and a mediator of child maltreatment with respect to psychopathological outcomes associated with substance abuse, including aggression and antisocial behavior.57, 58, 59, 60, 61, 62, 63, 64, 65, 66, 67, 68 Furthermore, the finding that child abuse interacts with MAOA genotype to predispose to tobacco and cannabis use helps qualify previous findings on the role of this gene as a moderator for the impact of lifetime stress on early substance use initiation.34, 35, 48

Our finding that the effects of MAOA are most evident among the individuals with a history of child physical abuse is consistent with prior research indicating that this type of maltreatment has greater effects on substance use than other forms of abuse (including sexual).94 Note that in the current study, we controlled for the statistical overlap in the maltreatment types, suggesting that physical abuse impacts the effects of MAOA in a specific fashion. Prior research also indicates that females exposed to physical abuse exhibit a greater risk of substance use than males94, 95, 96, 97, 98, 99; this sex‐specific vulnerability may account for the greater impact of physical abuse on cannabis use in female carriers of MAOA‐H variants. On the other hand, it is possible that this sex‐specific vulnerability may be confounded by different rates of physical abuse and substance use among males and females. With respect to these issues, it should be noted that physical abuse appears to be more common in boys than girls.100 Furthermore, Caucasian young females have been found to be at greater odds of lifetime use than males.101 It is important to note, however, that the severity level of maltreatment experienced in our sample is lower than the average rates observed in other populations, raising potential issues of representativeness of the general population.

Most studies on the phenotypic impact of MAOA have focused on aggression, violence, and antisocial behavior 57, 58, 59, 60, 61, 62, 63, 64, 65, 66, 67, 68 as well as depression 69, 70, 71, 72, 102, 103 and anxiety disorders.104, 105, 106 Similar to these findings, prior studies have shown a sex‐dimorphic effect of MAOA variants on psychopathology vulnerability, with MAOA‐L males and MAOA‐H females exhibiting a predisposition to antisocial responses.35, 36, 37, 38, 39, 40, 41, 42, 69, 70, 71, 72

Neuroimaging studies have highlighted the key role of MAOA in shaping the function of the anterior cingulate cortex (ACC).79, 107 This region is a major component of the brain circuitry subserving the control of executive functions, impulse control, and reward‐related behaviors.108, 109, 110, 111 The effects of MAOA on ACC activation patterns are sex‐dimorphic84; specifically, MAOA‐L male and MAOA‐H female carriers with a history of stress were shown to exhibit alterations in the activation of the ACC in response inhibition tasks.112 Functional impairments of the ACC (such as those predicted by the interaction of childhood stress and either MAOA‐H females or MAO‐L alleles in males) have been shown to lead to poor inhibitory control 113, 114 and increase substance use predisposition by facilitating the responses of the ventral striatum to incentive stimuli.115, 116 From this perspective, it is likely that these deficits in inhibitory control may arguably facilitate use of cannabis and tobacco in adolescence. Thus, our studies may suggest that sex‐dimorphic interactions of MAOA alleles and early maltreatment may facilitate inhibitory dyscontrol in adolescence and/or early adulthood, ultimately increasing the risk for tobacco smoking. Future analyses will be needed to verify whether specific domains of impulsivity may mediate the link between these G × E interactions and lifetime substance use.

One of the most commonly used frameworks to explain G × E interactions is the diathesis‐stress model, which posits that certain genotypic variants may predispose to a greater effect of stress (when it exceeds a given threshold) during a critical developmental window.117 In this case, the predisposition of MAOA‐H females and MAOA‐L males to a greater effect of stress may lead to a greater disinhibition phenotype, which may augment the likelihood to use substances in early developmental stages. From this perspective, it is worth mentioning that MAOA‐L male carriers have been shown to exhibit a greater neuroendocrine response to stress.118 An alternative model is afforded by the differential susceptibility hypothesis,119, 120 which postulates that genetic proneness accounts for sensitivity to both unfavorable and supportive environments.121 In line with this hypothesis, emerging evidence has pointed to the possibility that MAOA‐L variants may serve as “plasticity alleles” that may confer differential susceptibility to substance use depending on the sex and rearing environment.122, 123 For example, several authors have shown that boys carrying MAOA‐L variants are at greater risk for ADHD and conduct disorder if they had been subjected to high levels of adversity, but fewer mental problems if they were raised in nurturing environments.58, 124 Specifically, in males, MAOA‐L variants were found to predict for more or less criminal behavior, depending on different adversity histories.125

Previous studies have shown that MAOA variants can predict for higher risk of tobacco use disorder. Although our study was not focused on tobacco abuse or dependence, our data may suggest that the role of MAOA in increasing the risk for cigarette smoking may be influenced by early tobacco initiation. Indeed, previous studies have documented that early initiation of tobacco can predict higher risk for abuse and dependence in adulthood. This possibility, however, is partially challenged by the finding that MAOA‐H, rather than MAOA‐L, variants have been shown to increase the risk and severity for cigarette smoking in men.45, 47

The mechanisms of the interaction between sex and MAOA variants remain unclear, but may reflect a differential pattern of epigenetic inactivation, considering the sex‐specific methylation patterns of this gene.126, 127 This effect may be particularly relevant with respect to the escalation of tobacco use, given that smokers have lower methylation at two CpG islands associated with the MAOA promoter, in a fashion dependent from the uVNTR genotypes.44, 126 Similar effects were shown in relation to alcohol‐related problems in young adult males, in relation to both the interaction of MAOA uVNTR alleles and maltreatment.128

Androgens have been shown to modify the transcription of MAOA gene129; furthermore, testosterone has been shown to interact with MAOA uVNTR variants to predispose for aggression and risk‐taking behavior.65, 130 Future studies will be needed to verify the impact of testosterone and estrogens on the role of MAOA variants in substance abuse.

Several limitations of this study should be acknowledged. First, the study was conducted on 500 college students of predominantly Caucasian ethnic background. In consideration of the conceptual and methodological limitations of current research on G × E interactions in psychiatry,131, 132 these findings should be confirmed by further studies with larger, more ethnically diverse cohorts, which may increase their robustness and ascertain their generalizability. Second, the 3‐way interactions examined in this study do not reflect the full complexity of either genetic or environmental mechanisms in substance use. Future studies will also need to examine other environmental factors directly implicated in substance use in emerging adults, including parental rule setting, educational attainment, neighborhood characteristics, and peer influence.133, 134, 135 Third, our survey on tobacco and cannabis use was only limited to ascertain whether participants ever consumed any of these substances, but did not measure frequency and problematic patterns of use; future studies will be necessary to verify whether and how these aspects can be influenced by MAOA genotype. Fourth, current findings are based on retrospective self‐reports of child maltreatment; additionally, there was a low internal consistency associated with our measure of emotional neglect, which may have limited our ability to detect effects for this maltreatment type. Although several findings were evident in the current population and our measure of child maltreatment has been found to be psychometrically sound and widely used,82, 86 additional research in samples with more internally consistent measurement and have experienced elevated levels of maltreatment is warranted. Fifth, our analyses combined MAOA‐L and MAOA‐LH females; several studies have shown that, in females, the MAOA gene shows monoallelic expression due to Lyonization. Several studies suggest that X‐linked genes undergo variable inactivation,136 and thus, MAOA‐LH carriers may exhibit intermediate phenotypes between MAOA‐L and MAOA‐H carriers (see137 for a thorough analysis of this issue). Nevertheless, our analyses failed to show any statistically significant difference between MAOA‐LH and female MAO‐L carriers; thus, we adopted this analytical strategy to enable direct comparisons between sexes, in conformity with previous studies.84, 85, 86, 87, 88

These limitations notwithstanding, our data point to sex‐dimorphic G × E interactions in shaping the vulnerability for tobacco and cannabis use in college students. To the best of our knowledge, although G × E interactions are posited to play a central role in the pathogenesis of cannabis and tobacco use, very few studies have examined these mechanisms with most analyses focusing on serotonergic and dopaminergic genes.138 From this perspective, our recent analyses underscore the importance of gender as a factor in these analyses. In addition to MAOA, only very few genes have been shown to interact with environmental factors to influence the risk for psychopathology in a sex‐dimorphic fashion.139 On the one hand, sex remains a widely overlooked factor in most research on the genetic etiology of substance use139; on the other hand, it is possible that sex factors may be critical in differentiating the response to stress only with respect to specific gene pathways, such as those related to monoaminergic regulation. Our findings may have critical implications for the prevention of substance use, as they underscore the relevance of childhood trauma as an environmental determinant that may increase the vulnerability to tobacco use in MAOA‐L males and MAOA‐H females. Future studies confirming the involvement of MAOA as a differential susceptibility factor may be particularly critical to highlight the importance of good rearing environment for MAOA‐L boys and MAOA‐H girls.

Fite PJ, Brown S, Hossain W, Manzardo A, Butler MG, Bortolato M. Tobacco and cannabis use in college students are predicted by sex‐dimorphic interactions between MAOA genotype and child abuse. CNS Neurosci Ther. 2019;25:101–111. 10.1111/cns.13002

Contributor Information

Paula J. Fite, Email: pfite@ku.edu

Marco Bortolato, Email: marco.bortolato@utah.edu.

REFERENCES

  • 1. Vázquez FL. Psychoactive substance use and dependence among Spanish university students: prevalence, correlates, polyconsumption, and comorbidity with depression. Psychol Rep. 2010;106:297‐313. [DOI] [PubMed] [Google Scholar]
  • 2. Caamaño‐Isorna F, Mota N, Crego A, Corral M, Rodríguez Holguín S, Cadaveira F. Consumption of medicines, alcohol, tobacco and cannabis among university students: a 2‐year follow‐up. Int J Public Health. 2011;56:247‐252. [DOI] [PubMed] [Google Scholar]
  • 3. Primack BA, Kim KH, Shensa A, Sidani JE, Barnett TE, Switzer GE. Tobacco, marijuana, and alcohol use in university students: a cluster analysis. J Am Coll Health. 2012;60:374‐386. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 4. Tavolacci MP, Ladner J, Grigioni S, Richard L, Villet H, Dechelotte P. Prevalence and association of perceived stress, substance use and behavioral addictions: a cross‐sectional study among university students in France, 2009‐2011. BMC Public Health. 2013;13:724. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 5. Cho SB, Llaneza DC, Adkins AE, et al. Patterns of substance use across the first year of college and associated risk factors. Front Psychiatry. 2015;6:152. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 6. van Wel JH, Rosiers JF, Van Hal G. Changes in drug use among Belgian Higher education students: a comparison between 2005, 2009, and 2013. Subst Use Misuse. 2016;51:1232‐1238. [DOI] [PubMed] [Google Scholar]
  • 7. Schilling L, Zeeb H, Pischke C, et al. Licit and illicit substance use patterns among university students in Germany using cluster analysis. Subst Abuse Treat Prev Policy. 2017;12:44. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 8. Schulenberg JE, Johnston LD, O'Malley PM, Bachman JG, Miech RA, Patrick ME. Monitoring the Future National Survey Results On Drug Use, 1975–2016: Volume II, College Students And Adults Ages 19–55. Ann Arbor: Institute for Social Research, The University of Michigan; 2017. [Google Scholar]
  • 9. Perkins HW. Surveying the damage: a review of research on consequences of alcohol misuse in college populations. J Stud Alcohol Suppl 2002;s14:91‐100. [DOI] [PubMed] [Google Scholar]
  • 10. Zeigler DW, Wang CC, Yoast RA, et al., Council on Scientific Affairs, American Medical Association . The neurocognitive effects of alcohol on adolescents and college students. Prev Med. 2005;40:23‐32. [DOI] [PubMed] [Google Scholar]
  • 11. Hingson RW, Zha W, Weitzman ER. Magnitude of and trends in alcohol‐related mortality and morbidity among U.S. college students ages 18‐24, 1998‐2005. J Stud Alcohol Drugs Suppl 2009;s16:12‐20. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 12. Turner J, Keller A, Bauerle J. The longitudinal pattern of alcohol‐related injury in a college population: emergency department data compared to self‐reported data. Am J Drug Alcohol Abuse. 2010;36:194‐198. [DOI] [PubMed] [Google Scholar]
  • 13. Skidmore CR, Kaufman EA, Crowell SE. Substance use among college students. Child Adolesc Psychiatr Clin N Am. 2016;25:735‐753. [DOI] [PubMed] [Google Scholar]
  • 14. Ayala EE, Roseman D, Winseman JS, Mason HRC. Prevalence, perceptions, and consequences of substance use in medical students. Med Educ Online. 2017;22:1392824. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 15. Anthony JC, Petronis KR. Early‐onset drug use and risk of later drug problems. Drug Alcohol Depend. 1995;40:9‐15. [DOI] [PubMed] [Google Scholar]
  • 16. Chen CY, Storr CL, Anthony JC. Early‐onset drug use and risk for drug dependence problems. Addict Behav. 2009;34:319‐322. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 17. Richmond‐Rakerd LS, Slutske WS, Lynskey MT, et al. Age at first use and later substance use disorder: shared genetic and environmental pathways for nicotine, alcohol, and cannabis. J Abnorm Psychol. 2016;125:946‐959. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 18. Geels LM, Vink JM, Van Beijsterveldt CE, Bartels M, Boomsma DI. Developmental prediction model for early alcohol initiation in Dutch adolescents. J Stud Alcohol Drugs. 2013;74:59‐70. [DOI] [PubMed] [Google Scholar]
  • 19. Korhonen T, Latvala A, Dick DM, et al. Genetic and environmental influences underlying externalizing behaviors, cigarette smoking and illicit drug use across adolescence. Behav Genet. 2012;42:614‐625. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 20. Heath AC, Martin NG, Lynskey MT, Todorov AA, Madden PA. Estimating two‐stage models for genetic influences on alcohol, tobacco or drug use initiation and dependence vulnerability in twin and family data. Twin Res. 2002;5:113‐124. [DOI] [PubMed] [Google Scholar]
  • 21. Brook JS, Brook DW, Gordon AS, Whiteman M, Cohen P. The psychosocial etiology of adolescent drug use: a family interactional approach. Genet Soc Gen Psychol Monogr. 1990;116:111‐267. [PubMed] [Google Scholar]
  • 22. Hines LA, Morley KI, Mackie C, Lynskey M. Genetic and environmental interplay in adolescent substance use disorders. Curr Addict Rep. 2015;2:122‐129. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 23. Hammond CJ. Early childhood traumatic events and adolescent‐onset illicit drug use: implications for prevention and treatment. J Am Acad Child Adolesc Psychiatry. 2016;55:643‐644. [DOI] [PubMed] [Google Scholar]
  • 24. Forster M, Grigsby TJ, Rogers CJ, Benjamin SM. The relationship between family‐based adverse childhood experiences and substance use behaviors among a diverse sample of college students. Addict Behav. 2018;76:298‐304. [DOI] [PubMed] [Google Scholar]
  • 25. Tuliao AP, Jaffe AE, McChargue DE. Alcohol expectancies, posttraumatic stress disorder, and alcohol use in college students with a history of childhood trauma. J Dual Diagn 2016;12:4‐14. [DOI] [PubMed] [Google Scholar]
  • 26. Klanecky AK, Woolman EO, Becker MM. Child abuse exposure, emotion regulation, and drinking refusal self‐efficacy: an analysis of problem drinking in college students. Am J Drug Alcohol Abuse. 2015;41:188‐196. [DOI] [PubMed] [Google Scholar]
  • 27. Walsh K, Latzman NE, Latzman RD. Pathway from child sexual and physical abuse to risky sex among emerging adults: the role of trauma‐related intrusions and alcohol problems. J Adolesc Health. 2014;54:442‐448. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 28. Klanecky A, McChargue DE, Bruggeman L. Desire to dissociate: implications for problematic drinking in college students with childhood or adolescent sexual abuse exposure. Am J Addict. 2012;21:250‐256. [DOI] [PubMed] [Google Scholar]
  • 29. Chu DC. The links between religiosity, childhood sexual abuse, and subsequent marijuana use: an empirical inquiry of a sample of female college students. Int J Offender Ther Comp Criminol. 2012;56:937‐954. [DOI] [PubMed] [Google Scholar]
  • 30. Patock‐Peckham JA, Morgan‐Lopez AA. Direct and mediational links between parental bonds and neglect, antisocial personality, reasons for drinking, alcohol use, and alcohol problems. J Stud Alcohol Drugs. 2010;71:95‐104. [DOI] [PubMed] [Google Scholar]
  • 31. Young SE, Rhee SH, Stallings MC, Corley RP, Hewitt JK. Genetic and environmental vulnerabilities underlying adolescent substance use and problem use: general or specific? Behav Genet. 2006;36:603‐615. [DOI] [PubMed] [Google Scholar]
  • 32. Maes HH, Sullivan PF, Bulik CM, et al. A twin study of genetic and environmental influences on tobacco initiation, regular tobacco use and nicotine dependence. Psychol Med. 2004;34:1251‐1261. [DOI] [PubMed] [Google Scholar]
  • 33. Stringer S, Minică CC, Verweij KJ, et al. Genome‐wide association study of lifetime cannabis use based on a large meta‐analytic sample of 32 330 subjects from the International Cannabis Consortium. Transl Psychiatry. 2016;6:e769. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 34. Vanyukov MM, Moss HB, Yu L‐M, Tarter RE, Deka R. Preliminary evidence for an association of a dinucleotide repeat polymorphism at the MAOA gene with early onset alcoholism/substance abuse. Am J Med Genet (Neuropsychiat Genet). 1995;60:122‐126. [DOI] [PubMed] [Google Scholar]
  • 35. Vanyukov MM, Maher BS, Devlin B, et al. Haplotypes of the monoamine oxidase genes and the risk for substance use disorders. Am J Med Genet B Neuropsychiatr Genet. 2004;125B:120‐125. [DOI] [PubMed] [Google Scholar]
  • 36. Samochowiec J, Lesch KP, Rottmann M, et al. Association of a regulatory polymorphism in the promoter region of the monoamine oxidase A gene with antisocial alcoholism. Psychiatry Res. 1999;86:67‐72. [DOI] [PubMed] [Google Scholar]
  • 37. Schmidt LG, Sander T, Kuhn S, et al. Different allele distribution of a regulatory MAOA gene promoter polymorphism in antisocial and anxious‐depressive alcoholics. J Neural Transm. 2000;107:681‐689. [DOI] [PubMed] [Google Scholar]
  • 38. Contini V, Marques FZ, Garcia CE, Hutz MH, Bau CH. MAOA‐uVNTR polymorphism in a Brazilian sample: further support for the association with impulsive behaviors and alcohol dependence. Am J Med Genet B Neuropsychiatr Genet. 2006;141B:305‐308. [DOI] [PubMed] [Google Scholar]
  • 39. Guindalini C, Scivoletto S, Ferreira RG, et al. Association of MAO A polymorphism and alcoholism in Brazilian females. Psychiatr Genet. 2005;15:141‐144. [DOI] [PubMed] [Google Scholar]
  • 40. Herman AI, Kaiss KM, Ma R, et al. Serotonin transporter promoter polymorphism and monoamine oxidase type A VNTR allelic variants together influence alcohol binge drinking risk in young women. Am J Med Genet B Neuropsychiatr Genet. 2005;133B:74‐78. [DOI] [PubMed] [Google Scholar]
  • 41. Ducci F, Enoch MA, Hodgkinson C, et al. Interaction between a functional MAOA locus and childhood sexual abuse predicts alcoholism and antisocial personality disorder in adult women. Mol Psychiatry. 2008;13:334‐347. [DOI] [PubMed] [Google Scholar]
  • 42. Nilsson KW, Comasco E, Åslund C, Nordquist N, Leppert J, Oreland L. MAOA genotype, family relations and sexual abuse in relation to adolescent alcohol consumption. Addict Biol. 2011;16:347‐355. [DOI] [PubMed] [Google Scholar]
  • 43. Cervera‐Juanes R, Wilhem LJ, Park B, et al. MAOA expression predicts vulnerability for alcohol use. Mol Psychiatry. 2016;21:472‐479. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 44. Bendre M, Comasco E, Checknita D, Tiihonen J, Hodgins S, Nilsson KW. Associations Between MAOA‐uVNTR Genotype, Maltreatment, MAOA Methylation, and Alcohol Consumption in Young Adult Males. Alcohol Clin Exp Res. 2018;42:508‐519. [DOI] [PubMed] [Google Scholar]
  • 45. Wiesbeck GA, Wodarz N, Weijers HG, et al. A functional polymorphism in the promoter region of the monoamine oxidase A gene is associated with the cigarette smoking quantity in alcohol‐dependent heavy smokers. Neuropsychobiology. 2006;53:181‐185. [DOI] [PubMed] [Google Scholar]
  • 46. Jin Y, Chen D, Hu Y, et al. Association between monoamine oxidase gene polymorphisms and smoking behaviour in Chinese males. Int J Neuropsychopharmacol. 2006;9:557‐564. [DOI] [PubMed] [Google Scholar]
  • 47. Ito H, Hamajima N, Matsuo K, et al. Monoamine oxidase polymorphisms and smoking behaviour in Japanese. Pharmacogenetics. 2003;13:73‐79. [DOI] [PubMed] [Google Scholar]
  • 48. Stogner JM, Gibson CL. Stressful life events and adolescent drug use: moderating influences of the MAOA gene. J Crim Just. 2013;41:357‐363. [Google Scholar]
  • 49. Bortolato M, Chen K, Shih JC. Monoamine oxidase inactivation: from pathophysiology to therapeutics. Adv Drug Deliv Rev. 2008;60:1527‐1533. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 50. Bach AW, Lan NC, Johnson DL, et al. cDNA cloning of human liver monoamine oxidase A and B: molecular basis of differences in enzymatic properties. Proc Natl Acad Sci USA. 1988;85:4934‐4938. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 51. Grimsby J, Lan NC, Neve R, Chen K, Shih JC. Tissue distribution of human monoamine oxidase A and B mRNA. J Neurochem. 1990;55:1166‐1169. [DOI] [PubMed] [Google Scholar]
  • 52. Sabol SZ, Hu S, Hamer D. A functional polymorphism in the monoamine oxidase A gene promoter. Hum Genet. 1998;103:273‐279. [DOI] [PubMed] [Google Scholar]
  • 53. Huang YY, Cate SP, Battistuzzi C, Oquendo MA, Brent D, Mann JJ. An association between a functional polymorphism in the monoamine oxidase a gene promoter, impulsive traits and early abuse experiences. Neuropsychopharmacology. 2004;29:1498‐1505. [DOI] [PubMed] [Google Scholar]
  • 54. Deckert J, Catalano M, Syagailo YV, et al. Excess of high activity monoamine oxidase A gene promoter alleles in female patients with panic disorder. Hum Mol Genet. 1999;8:621‐624. [DOI] [PubMed] [Google Scholar]
  • 55. Denney RM, Koch H, Craig IW. Association between monoamine oxidase A activity in human male skin fibroblasts and genotype of the MAOA promoter‐associated variable number tandem repeat. Hum Genet. 1999;105:542‐551. [DOI] [PubMed] [Google Scholar]
  • 56. Jönsson EG, Norton N, Gustavsson JP, Oreland L, Owen MJ, Sedvall GC. A promoter polymorphism in the monoamine oxidase A gene and its relationships to monoamine metabolite concentrations in CSF of healthy volunteers. J Psychiatr Res. 2000;34:239‐244. [DOI] [PubMed] [Google Scholar]
  • 57. Caspi A, McClay J, Moffitt TE, et al. Role of genotype in the cycle of violence in maltreated children. Science. 2002;297:851‐854. [DOI] [PubMed] [Google Scholar]
  • 58. Kim‐Cohen J, Caspi A, Taylor A, et al. MAOA, maltreatment, and gene‐environment interaction predicting children's mental health: new evidence and a meta‐analysis. Mol Psychiatry. 2006;11:903‐913. [DOI] [PubMed] [Google Scholar]
  • 59. Fergusson DM, Boden JM, Horwood LJ, Miller A, Kennedy MA. Moderating role of the MAOA genotype in antisocial behaviour. Br J Psychiatry. 2012;200:116‐123. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 60. Byrd AL, Manuck SB. MAOA, childhood maltreatment, and antisocial behavior: meta‐analysis of a gene‐environment interaction. Biol Psychiatry. 2014;75:9‐17. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 61. Fergusson DM, Boden JM, Horwood LJ, Miller AL, Kennedy MA. MAOA, abuse exposure and antisocial behaviour: 30‐year longitudinal study. Br J Psychiatry. 2011;198:457‐463. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 62. Aslund C, Nordquist N, Comasco E, Leppert J, Oreland L, Nilsson KW. Maltreatment, MAOA, and delinquency: sex differences in gene‐environment interaction in a large population‐based cohort of adolescents. Behav Genet. 2011;41:262‐272. [DOI] [PubMed] [Google Scholar]
  • 63. Beaver KM, DeLisi M, Vaughn MG, Barnes JC. Monoamine oxidase A genotype is associated with gang membership and weapon use. Compr Psychiatry. 2010;51:130‐134. [DOI] [PubMed] [Google Scholar]
  • 64. Godar SC, Fite PJ, McFarlin KM, Bortolato M. The role of monoamine oxidase A in aggression: current translational developments and future challenges. Prog Neuropsychopharmacol Biol Psychiatry. 2016;69:90‐100. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 65. Sjöberg RL, Nilsson KW, Wargelius HL, Leppert J, Lindström L, Oreland L. Adolescent girls and criminal activity: role of MAOA‐LPR genotype and psychosocial factors. Am J Med Genet B Neuropsychiatr Genet. 2007;144B:159‐164. [DOI] [PubMed] [Google Scholar]
  • 66. McGrath LM, Mustanski B, Metzger A, et al. A latent modeling approach to genotype‐phenotype relationships: maternal problem behavior clusters, prenatal smoking, and MAOA genotype. Arch Womens Ment Health. 2012;15:269‐282. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 67. Verhoeven FE, Booij L, Kruijt AW, Cerit H, Antypa N, Does W. The effects of MAOA genotype, childhood trauma, and sex on trait and state‐dependent aggression. Brain Behav. 2012;2:806‐813. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 68. Byrd AL, Manuck SB, Hawes SW, et al. The interaction between monoamine oxidase A (MAOA) and childhood maltreatment as a predictor of personality pathology in females: emotional reactivity as a potential mediating mechanism. Dev Psychopathol. 2018;22:1‐17. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 69. Melas PA, Wei Y, Wong CC, et al. Genetic and epigenetic associations of MAOA and NR3C1 with depression and childhood adversities. Int J Neuropsychopharmacol. 2013;16:1513‐1528. [DOI] [PubMed] [Google Scholar]
  • 70. Nikulina V, Widom CS, Brzustowicz LM. Child abuse and neglect, MAOA, and mental health outcomes: a prospective examination. Biol Psychiatry. 2012;71:350‐357. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 71. Aklillu E, Karlsson S, Zachrisson OO, Ozdemir V, Agren H. Association of MAOA gene functional promoter polymorphism with CSF dopamine turnover and atypical depression. Pharmacogenet Genomics. 2009;19:267‐275. [DOI] [PubMed] [Google Scholar]
  • 72. Gillespie NA, Neale MC, Kendler KS. Pathways to cannabis abuse: a multi‐stage model from cannabis availability, cannabis initiation and progression to abuse. Addiction. 2009;104:430‐438. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 73. Agrawal A, Neale MC, Jacobson KC, Prescott CA, Kendler KS. Illicit drug use and abuse/dependence: modeling of two‐stage variables using the CCC approach. Addict Behav. 2005;30:1043‐1048. [DOI] [PubMed] [Google Scholar]
  • 74. Kendler KS, Karkowski LM, Corey LA, Prescott CA, Neale MC. Genetic and environmental risk factors in the aetiology of illicit drug initiation and subsequent misuse in women. Br J Psychiatry. 1999;175:351‐356. [DOI] [PubMed] [Google Scholar]
  • 75. Guy SM, Smith GM, Bentler PM. Consequences of adolescent drug use and personality factors on adult drug use. J Drug Educ. 1994;24:109‐132. [DOI] [PubMed] [Google Scholar]
  • 76. Brady KT, Myrick H, McElroy S. The relationship between substance use disorders, impulse control disorders, and pathological aggression. Am J Addict. 1998;7:221‐230. [PubMed] [Google Scholar]
  • 77. Ivanov I, Schulz KP, London ED, Newcorn JH. Inhibitory control deficits in childhood and risk for substance use disorders: a review. Am J Drug Alcohol Abuse. 2008;34:239‐258. [DOI] [PubMed] [Google Scholar]
  • 78. Passamonti L, Fera F, Magariello A, et al. Monoamine oxidase‐a genetic variations influence brain activity associated with inhibitory control: new insight into the neural correlates of impulsivity. Biol Psychiatry. 2006;59:334‐340. [DOI] [PubMed] [Google Scholar]
  • 79. Stoltenberg SF, Christ CC, Highland KB. Serotonin system gene polymorphisms are associated with impulsivity in a context dependent manner. Prog Neuropsychopharmacol Biol Psychiatry. 2012;39:182‐191. [DOI] [PubMed] [Google Scholar]
  • 80. Aiken LS, West SG. Multiple Regression: Testing And Interpreting Interactions. Newbury Park: Sage; 1991. [Google Scholar]
  • 81. Bernstein DP, Fink L. Childhood Trauma Questionnaire: A Retrospective Self‐Report Manual. San Antonio, TX: The Psychological Corporation; 1998. [Google Scholar]
  • 82. Pentz MA, MacKinnon DP, Flay BR, Hansen WB, Johnson CA, Dwyer JH. Primary prevention of chronic diseases in adolescence: effects of the Midwestern Prevention Project on tobacco use. Am J Epidemiol. 1989;130:713‐724. [DOI] [PubMed] [Google Scholar]
  • 83. Meyer‐Lindenberg A, Buckholtz JW, Kolachana BR, et al. Neural mechanisms of genetic risk for impulsivity and violence in humans. Proc Natl Acad Sci USA. 2006;103:6269‐6274. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 84. Fan J, Fossella J, Sommer T, Wu Y, Posner MI. Mapping the genetic variation of executive attention onto brain activity. Proc Natl Acad Sci USA. 2003;100:7406‐7411. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 85. Dannlowski U, Ohrmann P, Konrad C, et al. Reduced amygdala‐prefrontal coupling in major depression: association with MAOA genotype and illness severity. Int J Neuropsychopharmacol. 2009;12:11‐22. [DOI] [PubMed] [Google Scholar]
  • 86. Frazzetto G, Di Lorenzo G, Carola V, et al. Early trauma and increased risk for physical aggression during adulthood: the moderating role of MAOA genotype. PLoS ONE. 2007;2:e486. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 87. Buckholtz JW, Callicott JH, Kolachana B, et al. Genetic variation in MAOA modulates ventromedial prefrontal circuitry mediating individual differences in human personality. Mol Psychiatry. 2008;13:313‐324. [DOI] [PubMed] [Google Scholar]
  • 88. Nakagawa S. A farewell to Bonferroni: the problems of low statistical power and publication bias. Behav Ecology. 2004;15:1044‐1045. [Google Scholar]
  • 89. Tabachnick BG, Fidell LS. Using Multivariate Statistics. Boston: Allyn and Bacon; 2001. [Google Scholar]
  • 90. Reichert EL, Flannery‐Schroeder E. Posttraumatic cognitions as mediators between childhood maltreatment and poorer mental health among young adults. J Child Adolesc Trauma. 2014;7:153‐162. [Google Scholar]
  • 91. Anda RF, Whitfield CL, Felitti VJ, et al. Adverse childhood experiences, alcoholic parents, and later risk of alcoholism and depression. Psychiatr Serv. 2002;53:1001‐1009. [DOI] [PubMed] [Google Scholar]
  • 92. Dube SR, Felitti VJ, Dong M, Chapman DP, Giles WH, Anda RF. Childhood abuse, neglect, and household dysfunction and the risk of illicit drug use: the adverse childhood experiences study. Pediatrics. 2003;111:564‐572. [DOI] [PubMed] [Google Scholar]
  • 93. Dube SR, Anda RF, Felitti VJ, Edwards VJ, Croft JB. Adverse childhood experiences and personal alcohol abuse as an adult. Addict Behav. 2002;27:713‐725. [DOI] [PubMed] [Google Scholar]
  • 94. Dembo R, Williams L, Schmeidler J, et al. A structural model examining the relationship between physical child abuse, sexual victimization, and marijuana/hashish use in delinquent youth: a longitudinal study. Violence Vict. 1992;7:41‐62. [PubMed] [Google Scholar]
  • 95. Swett C Jr, Cohen C, Surrey J, Compaine A, Chavez R. High rates of alcohol use and history of physical and sexual abuse among women outpatients. Am J Drug Alcohol Abuse. 1991;17:49‐60. [DOI] [PubMed] [Google Scholar]
  • 96. Swett C, Halpert M. High rates of alcohol problems and history of physical and sexual abuse among women inpatients. Am J Drug Alcohol Abuse. 1994;20:263‐272. [DOI] [PubMed] [Google Scholar]
  • 97. Widom CS, White HR. Problem behaviors in abused and neglected children grown‐up: prevalence and co‐occurrence of substance abuse, crime, and violence. Criminal Behav Mental Health. 1997;7:287‐310. [Google Scholar]
  • 98. McClellan DS, Farabee D, Crouch BM. Early victimization, drug use, and criminality: a comparison of male and female prisoners. Criminal Justice Behav. 1997;24:455‐477. [Google Scholar]
  • 99. Widom CS, Weiler BL, Cottler LB. Childhood victimization and drug abuse: a comparison of prospective and retrospective findings. J Consult Clin Psychol. 1999;67:867‐880. [DOI] [PubMed] [Google Scholar]
  • 100. Thompson MP, Kingree JB, Desai S. Gender differences in long‐term health consequences of physical abuse of children: data from a nationally representative survey. Am J Public Health. 2004;94:599‐604. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 101. Schepis TS, Desai RA, Cavallo DA, et al. Gender differences in adolescent marijuana use and associated psychosocial characteristics. J Addict Med. 2011;5:65‐73. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 102. Gutiérrez B, Arias B, Gastó C, et al. Association analysis between a functional polymorphism in the monoamine oxidase A gene promoter and severe mood disorders. Psychiatr Genet. 2004;14:203‐208. [DOI] [PubMed] [Google Scholar]
  • 103. Yu YW, Yang CW, Wu HC, et al. Association study of a functional MAOA‐uVNTR gene polymorphism and personality traits in Chinese young females. Neuropsychobiology. 2005;52:118‐121. [DOI] [PubMed] [Google Scholar]
  • 104. Samochowiec J, Hajduk A, Samochowiec A, et al. Association studies of MAO‐A, COMT, and 5‐HTT genes polymorphisms in patients with anxiety disorders of the phobic spectrum. Psychiatry Res. 2004;128:21‐26. [DOI] [PubMed] [Google Scholar]
  • 105. Maron E, Lang A, Tasa G, et al. Associations between serotonin‐related gene polymorphisms and panic disorder. Int J Neuropsychopharmacol. 2005;8:261‐266. [DOI] [PubMed] [Google Scholar]
  • 106. Reif A, Weber H, Domschke K, et al. Meta‐analysis argues for a female‐specific role of MAOA‐uVNTR in panic disorder in four European populations. Am J Med Genet B Neuropsychiatr Genet. 2012;159B:786‐793. [DOI] [PubMed] [Google Scholar]
  • 107. Passamonti L, Cerasa A, Gioia MC, et al. Genetically dependent modulation of serotonergic inactivation in the human prefrontal cortex. NeuroImage. 2008;40:1264‐1273. [DOI] [PubMed] [Google Scholar]
  • 108. Goldstein RZ, Volkow ND. Drug addiction and its underlying neurobiological basis: neuroimaging evidence for the involvement of the frontal cortex. Am J Psychiatry. 2002;159:1642‐1652. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 109. Koob GF. The neurobiology of addiction: a neuroadaptational view relevant for diagnosis. Addiction. 2006;101(Suppl 1):23‐30. [DOI] [PubMed] [Google Scholar]
  • 110. Yücel M, Lubman DI. Neurocognitive and neuroimaging evidence of behavioural dysregulation in human drug addiction: implications for diagnosis, treatment and prevention. Drug Alcohol Rev. 2007;26:33‐39. [DOI] [PubMed] [Google Scholar]
  • 111. Goldstein RZ, Alia‐Klein N, Tomasi D, et al. Anterior cingulate cortex hypoactivations to an emotionally salient task in cocaine addiction. Proc Natl Acad Sci USA. 2009;106:9453‐9458. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 112. Holz N, Boecker R, Buchmann AF, et al. Evidence for a sex‐dependent MAOA× childhood stress interaction in the neural circuitry of aggression. Cereb Cortex. 2016;26:904‐914. [DOI] [PubMed] [Google Scholar]
  • 113. Chan AS, Han YM, Leung WW, Leung C, Wong VC, Cheung M. Abnormalities in the anterior cingulate cortex associated with attentional and inhibitory control deficits: a neurophysiological study on children with autism spectrum disorders. Res Autism Spectr Disord. 2011;5:254‐266. [Google Scholar]
  • 114. Bush G, Luu P, Posner MI. Cognitive and emotional influences in anterior cingulate cortex. Trends Cogn Sci. 2000;4:215‐222. [DOI] [PubMed] [Google Scholar]
  • 115. Holmes AJ, Hollinshead MO, Roffman JL, Smoller JW, Buckner RL. Individual differences in cognitive control circuit anatomy link sensation seeking, impulsivity, and substance use. J Neurosci. 2016;36:4038‐4049. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 116. Koyama MS, Parvaz MA, Goldstein RZ. The adolescent brain at risk for substance use disorders: a review of functional MRI research on motor response inhibition. Curr Opin Behav Sci. 2017;13:186‐195. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 117. Zuckerman M. Diathesis‐stress models In: Zuckerman M, ed. Vulnerability to Psychopathology: A Biosocial Model. Washington, DC: American Psychological Association; 1999:3‐23. [Google Scholar]
  • 118. Jabbi M, Korf J, Kema IP, et al. Convergent genetic modulation of the endocrine stress response involves polymorphic variations of 5‐HTT, COMT and MAOA. Mol Psychiatry. 2007;12:483‐490. [DOI] [PubMed] [Google Scholar]
  • 119. Belsky J. Theory testing, effect‐size evaluation, and differential susceptibility to rearing influence: the case of mothering and attachment. Child Dev. 1997;68:598‐600. [PubMed] [Google Scholar]
  • 120. Ellis BJ, Boyce WT, Belsky J, Bakermans‐Kranenburg MJ, van Ijzendoorn MH. Differential susceptibility to the environment: an evolutionary–neurodevelopmental theory. Dev Psychopathol. 2011;23:7‐28. [DOI] [PubMed] [Google Scholar]
  • 121. Boyce WT, Ellis BJ. Biological sensitivity to context: I. An evolutionary‐developmental theory of the origins and functions of stress reactivity. Dev Psychopathol. 2005;17:271‐301. [DOI] [PubMed] [Google Scholar]
  • 122. Belsky J, Jonassaint C, Pluess M, Stanton M, Brummett B, Williams R. Vulnerability genes or plasticity genes? Mol Psychiatry. 2009;14:746‐754. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 123. Belsky J, Beaver KM. Cumulative‐genetic plasticity, parenting and adolescent self‐regulation. J Child Psychol Psychiatry. 2011;52:619‐626. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 124. Foley DL, Eaves LJ, Wormley B, et al. Childhood adversity, monoamine oxidase a genotype, and risk for conduct disorder. Arch Gen Psychiatry. 2004;61:738‐744. [DOI] [PubMed] [Google Scholar]
  • 125. Nilsson KW, Sjoberg RL, Damberg M, et al. Role of monoamine oxidase A genotype and psychosocial factors in male adolescent criminal activity. Biol Psychiatry. 2006;59:121‐127. [DOI] [PubMed] [Google Scholar]
  • 126. Philibert RA, Gunter TD, Beach SR, Brody GH, Madan A. MAOA methylation is associated with nicotine and alcohol dependence in women. Am J Med Genet B Neuropsychiatr Genet. 2008;147B:565‐570. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 127. Domschke K, Tidow N, Kuithan H, et al. Monoamine oxidase A gene DNA hypomethylation ‐ a risk factor for panic disorder? Int J Neuropsychopharmacol. 2012;15:1217‐1228. [DOI] [PubMed] [Google Scholar]
  • 128. Philibert RA, Beach SRH, Gunter TD, Brody GH, Madan A, Gerrard M. The effect of smoking on MAOA promoter methylation in DNA prepared from lymphoblasts and whole blood. Am J Med Genet B Neuropsychiatr Genet. 2010;153B:619‐628. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 129. Ou XM, Chen K, Shih JC. Glucocorticoid and androgen activation of monoamine oxidase A is regulated differently by R1 and Sp1. J Biol Chem. 2006;281:21512‐21525. [DOI] [PubMed] [Google Scholar]
  • 130. Wagels L, Votinov M, Radke S, et al. Blunted insula activation reflects increased risk and reward seeking as an interaction of testosterone administration and the MAOA polymorphism. Hum Brain Mapp. 2017;38:4574‐4593. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 131. Duncan LE, Keller MC. A critical review of the first 10 years of candidate gene‐by‐environment interaction research in psychiatry. Am J Psychiatry. 2001;168:1041‐1049. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 132. Samek DR, Bailey J, Hill KG, et al. A test‐replicate approach to candidate gene research on addiction and externalizing disorders: a collaboration across five longitudinal studies. Behav Genet. 2016;46:608‐626. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 133. White HR, McMorris BJ, Catalano RF, Fleming CB, Haggerty KP, Abbott RD. Increases in alcohol and marijuana use during the transition out of high school into emerging adulthood: The effects of leaving home, going to college, and high school protective factors. J Stud Alcohol. 2006;67:810‐822. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 134. Schepis TS, Rao U. Epidemiology and etiology of adolescent smoking. Curr Opin Pediatr. 2005;17:607‐612. [DOI] [PubMed] [Google Scholar]
  • 135. Kirst M, Mecredy G, Borland T, Chaiton M. Predictors of substance use among young adults transitioning away from high school: a narrative review. Subst Use Misuse. 2014;49:1795‐1807. [DOI] [PubMed] [Google Scholar]
  • 136. Carrel L, Willard HF. X‐inactivation profile reveals extensive variability in X‐linked gene expression in females. Nature. 2005;434:400‐404. [DOI] [PubMed] [Google Scholar]
  • 137. Prom‐Wormley EC, Eaves LJ, Foley DL, et al. Monoamine oxidase A and childhood adversity as risk factors for conduct disorder in females. Psychol Med. 2009;39:579‐590. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 138. Milaniak I, Watson B, Jaffee SR. Gene‐environment interplay and substance use: a review of recent findings. Curr Addict Rep. 2015;2:364‐371. [Google Scholar]
  • 139. Perry BL, Pescosolido BA, Bucholz K, et al. Gender‐specific gene–environment interaction in alcohol dependence: the impact of daily life events and GABRA2. Behav Genet. 2013;43:402‐414. [DOI] [PMC free article] [PubMed] [Google Scholar]

Articles from CNS Neuroscience & Therapeutics are provided here courtesy of Wiley

RESOURCES